About The Medical Condition EN-1639A
Find the definition of the medical term EN-1639A. EN-1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
EN-1639A
| EN-1639A Medical Condition |
|---|
What's The Definition Of The Medical Condition EN-1639A?
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Promotor Region (Genetics) ‐ DNA sequences which are recognized (directly or indirectly) and…
- Cancer, Auricular ‐ Tumors or cancer of the internal, external, or…
- Toxin, beta-Scorpion ‐ Venoms from animals of the order Scorpionida of the class Arachnida.…
- Diseases, Iris ‐ Diseases, dysfunctions, or disorders of or located in…
- Mating Behavior, Animal ‐ Sexual activities…
- Promotion, Health ‐ Encouraging consumer behaviors most likely to optimize health…
- Carbamoyl Transferases ‐ A group of enzymes that catalyze the transfer of carboxyl- or…
- Catheterization, Balloon ‐ Nonoperative repair of occluded vessels, ducts, or valves by…
- Endo-1,4-beta-Glucanase ‐ An enzyme isolated from fungi and bacteria. It catalyzes the…
- Deiodinase ‐ A hemeprotein that catalyzes the oxidation of the iodide radical…